EICHOR
● Active Not Recruiting
A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC
Condition: Non Small Cell Lung Cancer · Sponsor: Shanghai Chest Hospital
About this study
The goal of this prospective, observational study is to explore the value of dynamic monitoring of minimal residual lesions in driver mutated stage III NSCLC for disease recurrence and prognosis assessment. The main question it aims to answer is: 1\) Whether MRD(Minimal residual disease) status can predict recurrence events in stage III driven-mutant NSCLC in advance
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (14)
| The First Affiliated Hospital of USTC / Anhui Provincial Hospital | Hefei, Anhui, China | — |
| First Affiliated Hospital of Xiamen University | Xiamen, Fujian, China | — |
| The First Affiliated Hospital of Guangzhou Medical University | Guangzhou, Guangdong, China | — |
| Affiliated Cancer Hospital of Harbin Medical University | Harbin, Heilongjiang, China | — |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou, Henan, China | — |
| Hunan Cancer Hospital | Changsha, Hunan, China | — |
| Qilu Hospital of Shandong University | Jinan, Shandong, China | — |
| Shandong Provincial Hospital | Jinan, Shandong, China | — |
| Shanghai Chest hospital | Shanghai, Shanghai Municipality, China | — |
| Zhongshan Hospital Affiliated to Fudan University | Shanghai, Shanghai Municipality, China | — |
| Shanxi Cancer Hospital | Taiyuan, Shanxi, China | — |
| The First Affiliated Hospital of Xi 'an Jiaotong University | Xi’an, Shanxi, China | — |
+ 2 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06443684